Ryo Honda

8PUBLICATIONS
5CO-AUTHORS
Gene and molecular therapyMolecular targetsInorganic materials (incl. nanomaterials)Proteins and peptidesToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 03, 2026
Thermal Stability, Plasma Pharmacokinetics, and Tumor Response Modeling of a Cell-Penetrating Protein That Cleaves RAS Family GTPases.

|Aug 06, 2026
Daraxonrasib and Beyond: Pan-RAS Inhibition, Resistance, and Next-Generation Strategies.

|May 16, 2026
Protein-based pan-RAS inhibitor induces tumor regression in female mice via IFNγ and CD8+ T cell-dependent tumor necrosis.

|Apr 14, 2021
Monomeric a-synuclein (aS) inhibits amyloidogenesis of human prion protein (hPrP) by forming a stable aS-hPrP hetero-dimer.

Satoshi Yamashita, Yuji O Kamatari, Ryo Honda

|Jan 24, 2020
Discovery of a multipotent chaperone, 1-(2,6-Difluorobenzylamino)-3-(1,2,3,4-tetrahydrocarbazol-9-yl)-propan-2-ol with the inhibitory effects on the proliferation of prion, cancer as well as influenza virus.

Satoshi Yamashita, Ryo Honda, Mayuko Fukuoka

|Aug 04, 2018
Poly-L-histidine inhibits prion propagation in a prion-infected cell line.

Ryo Honda, Kei-Ichi Yamaguchi, Abdelazim Elsayed Elhelaly

Pageof 2

Frequent Collaborators

1 joint publications

Kazuki Heishima

1 joint publications

Hirobumi Fuchigami

1 joint publications

Fuminori Hyodo

1 joint publications

Masahiro Yasunaga